Pfizer Venture Investments led the small-molecule cancer drug developer's $38.6m series C round, which included Novartis, GlaxoSmithkline, AbbVie and Astellas.

Living Pharma, an immunotherapy developer, has been acquired just 18 months after being spun out from University of Maryland.

Blue Cross Blue Shield of Massachusetts' Zaffre Investments fund has joined the investors in electronic health record analytics platform Arcadia Healthcare Solutions.

BGU spinout Neuroderm, which is developing clinical-stage pumps containing medicine for Parkinson’s, has been bought by Mitsubishi Tanabe Pharma for $1.1bn.

Vitreoretinal disease therapy developer Allegro Ophthalmics has raised $10.7m in funding, 18 months after receiving $20m from Hanmi Pharmaceutical.

Novartis and Sanofi-Genzyme have co-led a first funding round for NeuroVia, which will use the cash to advance development of a drug for a rare genetic neurological disease.

Medical device developer Amphora Medical has closed a $35.5m series B round co-led by Boston Scientific that will fund a pivotal study for its OAB treatment.

University of New Mexico has revealed it generated 12 new businesses during its financial year that ended June 30.